Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0OYGDO
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
EP4227309A4 ADC-19
|
|||||
| Synonyms |
ADC-19
Click to Show/Hide
|
|||||
| Organization |
SICHUAN BAILI PHARMACEUTICAL CO. LTD. | SYSTIMMUNE, INC.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
7.3
|
|||||
| Structure |
|
|||||
| Antibody Name |
Cetuximab
|
Antibody Info | ||||
| Antigen Name |
Epidermal growth factor receptor (EGFR)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Therapeutic Target |
Stimulator of interferon genes protein (STING1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
| Combination Type |
L-D3
|
|||||